[Chronic renal insufficiency and cardiovascular disease].
Renal insufficiency is frequently seen in patients with cardiovascular disease. In contrast, coronary artery disease is the leading cause of death in patients with renal impairment. The recognition of renal insufficiency is essential in these patients and preventive measures must be put in place to prevent the progression or onset of cardiovascular disease. In this article, we explain the methods to assess kidney function, the epidemiology of coronary heart disease in patients with renal impairment, risk factors conventional and non-conventional found in these patients and the main recommendations for their therapeutic care.
Charriere
S
S
Service d'endocrinologie et métabolismes, hôpital Louis-Pradel, Bron, 59, boulevard Pinel, 69677 Bron, France.
Rognant
N
N
Chiche
F
F
Cremer
A
A
Deray
G
G
Priou
M
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000465:Algorithms; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D055316:Cystatin C / Q000097:blood; D004359:Drug Therapy, Combination; D005602:France / Q000453:epidemiology; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008019:Life Style; D017410:Practice Guidelines as Topic; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D015415:Biomarkers; D055316:Cystatin C; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D003404:Creatinine